- Home
- TXRH vs MEDP Comparison
TXRH vs MEDP Comparison
Compare TXRH & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- MEDP
- Stock Information
- Founded
- TXRH 1993
- MEDP 1992
- Country
- TXRH United States
- MEDP United States
- Employees
- TXRH N/A
- MEDP N/A
- Industry
- TXRH Restaurants
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TXRH Consumer Discretionary
- MEDP Health Care
- Exchange
- TXRH Nasdaq
- MEDP Nasdaq
- Market Cap
- TXRH 11.2B
- MEDP 10.5B
- IPO Year
- TXRH 2004
- MEDP 2016
- Fundamental
- Price
- TXRH $166.63
- MEDP $304.69
- Analyst Decision
- TXRH Buy
- MEDP Buy
- Analyst Count
- TXRH 24
- MEDP 10
- Target Price
- TXRH $192.13
- MEDP $373.22
- AVG Volume (30 Days)
- TXRH 1.1M
- MEDP 399.6K
- Earning Date
- TXRH 05-01-2025
- MEDP 04-21-2025
- Dividend Yield
- TXRH 1.63%
- MEDP N/A
- EPS Growth
- TXRH 42.51
- MEDP 42.23
- EPS
- TXRH 6.47
- MEDP 12.63
- Revenue
- TXRH $5,373,332,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- TXRH $10.79
- MEDP $4.45
- Revenue Next Year
- TXRH $8.80
- MEDP $9.67
- P/E Ratio
- TXRH $25.75
- MEDP $24.12
- Revenue Growth
- TXRH 16.01
- MEDP 11.84
- 52 Week Low
- TXRH $146.75
- MEDP $289.01
- 52 Week High
- TXRH $206.04
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- TXRH 39.31
- MEDP 34.76
- Support Level
- TXRH $167.88
- MEDP $310.29
- Resistance Level
- TXRH $179.59
- MEDP $331.24
- Average True Range (ATR)
- TXRH 4.64
- MEDP 9.40
- MACD
- TXRH -0.27
- MEDP -1.29
- Stochastic Oscillator
- TXRH 20.34
- MEDP 35.04
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company's operating segment includes Texas Roadhouse; Bubba's 33 and others. It generates maximum revenue from the Texas Roadhouse segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.